Decision

Advertising investigations: October 2014

Decisions made by MHRA following an investigation into complaints about advertising for licensed medicines.

• From: Medicines and Healthcare products Regulatory Agency
• Published: 28 January 2015

Documents

15 October 2014: promotion of PSD502

HTML

31 October 2014: clinics advertising botulinum toxin products

HTML

Details

Contact advertising@mhra.gsi.gov.uk if you have concerns with the advertising of medicines or write to:

Advertising Standards Unit,
Area 0-3, 151 Buckingham Palace Road,
Victoria,
London SW1W 9SZ.

Alternatively, contact the pharmaceutical self-regulatory bodies, the Proprietary Association of Great Britain (PAGB) for advertising for over the counter medicines, or the Prescription Medicines Code of Practice Authority (PMCPA) for advertisements to health professionals for prescription medicines.

Published 28 January 2015